Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?

World Journal of Surgery

Volumn 34, Issue 6, 2010, Pages 1294-1298

  Skandarajah, Anita ^a   Barlier, Anne ^b   Morlet Barlat, Nathalie ^a   Sebag, Frederic ^a   Enjalbert, Alain ^b   Conte Devolx, Bernard ^a   Henry, Jean François ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEN1 PROTEIN, HUMAN; ONCOPROTEIN;

ADOLESCENT; ADULT; AGE; ARTICLE; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; METHODOLOGY; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PARATHYROIDECTOMY; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 77955552244     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0388-5     Document Type: Article

References (38)

1. Cetani F, Pardi E, Ambrogini E et al (2006) Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. Clin Endocrinol (Oxf) 64:146-152
2. Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671
3. Glascock MJ, Carty SE (2002) Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance. Surg Oncol 11:143-150
4. Allo M, Thompson NW, Harness JK et al (1982) Primary hyperparathyroidism in children, adolescents, and young adults. World J Surg 6:771-776
5. Harman CR, van Heerden JA, Farley DR et al (1999) Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg 134:651-655 (discussion 655-656)
6. Karges W, Schaaf L, Dralle H et al (2002) Clinical and molecular diagnosis of multiple endocrine neoplasia type 1. Langenbecks Arch Surg 386:547-552
7. Benson L, Ljunghall S, Akerstrom G et al (1987) Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med 82:731-737
8. Larsson C, Skogseid B, Oberg K et al (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87
9. Lemos MC, Thakker RV (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22-32
10. Cupisti K, Raffel A, Dotzenrath C et al (2004) Primary hyperparathyroidism in the young age group: particularities of diagnostic and therapeutic schemes. World J Surg 28:1153-1156
11. Uchino S, Noguchi S, Sato M et al (2000) Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60:5553-5557
12. Ellard S, Hattersley AT, Brewer CM et al (2005) Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clin Endocrinol (Oxf) 62:169-175
13. Cardinal JW, Bergman L, Hayward N et al (2005) A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. J Med Genet 42:69-74
14. DeLellis RA, Mazzaglia P, Mangray S (2008) Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132:1251-1262
15. Langer P, Wild A, Hall A et al (2003) Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours. Br J Surg 90:1599-1603
16. Tham E, Grandell U, Lindgren E et al (2007) Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab 92:3389-3395
17. Villablanca A, Calender A, Forsberg L et al (2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41:e32
18. Schussheim DH, Skarulis MC, Agarwal SK et al (2001) Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 12:173-178
19. Adam LA, Smith BJ, Calva-Cerqueira D et al (2008) Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism. World J Surg 32:1518-1524
20. Joshua B, Feinmesser R, Ulanovski D et al (2004) Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg 131:628-632
21. Berger AC, Libutti SK, Bartlett DL et al (1999) Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia. J Am Coll Surg 188:382-389
22. Sitges-Serra A, Bergenfelz A (2007) Clinical update: sporadic primary hyperparathyroidism. Lancet 370:468-470
23. Wautot V, Vercherat C, Lespinasse J et al (2002) Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat 20:35-47
24. Berber E, Parikh RT, Ballem N et al (2008) Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery 144:74-79
25. Arici C, Cheah WK, Ituarte PH et al (2001) Can localization studies be used to direct focused parathyroid operations? Surgery 129:720-729
26. Koslin DB, Adams J, Andersen P et al (1997) Preoperative evaluation of patients with primary hyperparathyroidism: role of high-resolution ultrasound. Laryngoscope 107:1249-1253
27. Murchison J, McIntosh C, Aitken AG et al (1991) Ultrasonic detection of parathyroid adenomas. Br J Radiol 64:679-682
28. Arima M, Yokoi H, Sonoda T (1975) Preoperative identification of tumor of the parathyroid by ultrasonotomography. Surg Gynecol Obstet 141:242-244
29. Pyrtek LJ, McClelland AD (1983) Primary surgery for hyperparathyroidism: the lateral approach after preoperative ultrasonographic localization. Am J Surg 145:503-507
30. Mitchell BK, Cornelius EA, Zoghbi S et al (1996) Mechanism of technetium 99 m sestamibi parathyroid imaging and the possible role of p-glycoprotein. Surgery 120:1039-1045
31. Lavely WC, Goetze S, Friedman KP et al (2007) Comparison of SPECT/CT, SPECT, and planar imaging with single- and dualphase (99 m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med 48:1084-1089
32. Denham DW, Norman J (1998) Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 186:293-305
33. Trupka A, Hallfeldt K, Horn K et al (2001) Intraoperative monitoring of intact parathyroid hormone (iPTH) in surgery of primary hyperparathyroidism with a new rapid test. Chirurg 72: 578-583
34. Pellitteri P (2008) The role of intraoperative measurement of parathyroid hormone in parathyroid surgery. ORL J Otorhinolaryngol Relat Spec 70:319-330
35. Carneiro DM, Solorzano CC, Nader MC et al (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973-979 (discussion 979-981)
36. Miura D, Wada N, Arici C et al (2002) Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy? World J Surg 26:926-930
37. Sebag F, Hubbard JG, Maweja S et al (2003) Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery 134:1038-1041 (discussion 1041-1042)
38. Yip L, Ogilvie JB, Challinor SM et al (2008) Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism. Surgery 144:1002-1006 (discussion 1006-1007)